These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33183865)

  • 1. Synthesis of some new benzoxazole derivatives and investigation of their anticancer activities.
    Osmaniye D; Korkut Çelikateş B; Sağlık BN; Levent S; Acar Çevik U; Kaya Çavuşoğlu B; Ilgın S; Özkay Y; Kaplancıklı ZA
    Eur J Med Chem; 2021 Jan; 210():112979. PubMed ID: 33183865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors.
    El-Helby AA; Sakr H; Eissa IH; Abulkhair H; Al-Karmalawy AA; El-Adl K
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900113. PubMed ID: 31448458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of the anticancer activity of 2-amino-aryl-7-aryl-benzoxazole compounds.
    Khajondetchairit P; Phuangsawai O; Suphakun P; Rattanabunyong S; Choowongkomon K; Gleeson MP
    Chem Biol Drug Des; 2017 Nov; 90(5):987-994. PubMed ID: 28544428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative activity, enzymatic inhibition and apoptosis-promoting effects of benzoxazole-based hybrids on human breast cancer cells.
    Omar AME; AboulWafa OM; Amr ME; El-Shoukrofy MS
    Bioorg Chem; 2021 Apr; 109():104752. PubMed ID: 33657444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma.
    Dadashpour S; Küçükkılınç TT; Ercan A; Hosseinimehr SJ; Naderi N; Irannejad H
    Anticancer Agents Med Chem; 2019; 19(17):2120-2129. PubMed ID: 31393257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and
    Kuzu B; Hepokur C; Turkmenoglu B; Burmaoglu S; Algul O
    Future Med Chem; 2022 Jul; 14(14):1027-1048. PubMed ID: 35703122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase.
    Yuan X; Yang Q; Liu T; Li K; Liu Y; Zhu C; Zhang Z; Li L; Zhang C; Xie M; Lin J; Zhang J; Jin Y
    Eur J Med Chem; 2019 Oct; 179():147-165. PubMed ID: 31252306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents.
    Abdelgawad MA; Bakr RB; Omar HA
    Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 5-(or 6)-benzoxazoles and oxazolo[4,5-b]pyridines as novel candidate antitumor agents targeting hTopo IIα.
    Karatas E; Foto E; Ertan-Bolelli T; Yalcin-Ozkat G; Yilmaz S; Ataei S; Zilifdar F; Yildiz I
    Bioorg Chem; 2021 Jul; 112():104913. PubMed ID: 33945950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition.
    Abdelgawad MA; Bakr RB; Ahmad W; Al-Sanea MM; Elshemy HAH
    Bioorg Chem; 2019 Nov; 92():103218. PubMed ID: 31536956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison.
    Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Atlıd Ö; Atlı Eklioğlu Ö; Kaplancıklı ZA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1657-1673. PubMed ID: 32811204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new series of benzoxazole-based SIRT1 modulators for targeted therapy of non-small-cell lung cancer.
    Sever B; Akalın Çiftçi G; Altıntop MD
    Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000235. PubMed ID: 32930414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Novel Benzoxazole Linked 1,3,4-Oxadiazoles.
    Bujji S; Kumar EP; Sivan SK; Manjunatha DH; Subhashini NJP
    Anticancer Agents Med Chem; 2022; 22(5):933-942. PubMed ID: 34229589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity.
    Özdemir A; Altıntop MD; Kaplancıklı ZA; Turan-Zitouni G; Ciftçi GA; Yıldırım SU
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1221-7. PubMed ID: 23020635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro Anti-cancer assay and apoptotic cell pathway of newly synthesized benzoxazole-N-heterocyclic hybrids as potent tyrosine kinase inhibitors.
    Desai S; Desai V; Shingade S
    Bioorg Chem; 2020 Jan; 94():103382. PubMed ID: 31662214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1.
    Kumar D; Jacob MR; Reynolds MB; Kerwin SM
    Bioorg Med Chem; 2002 Dec; 10(12):3997-4004. PubMed ID: 12413851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents.
    El-Gohary NS; Shaaban MI
    Eur J Med Chem; 2017 May; 131():255-262. PubMed ID: 28334654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel benzothiazole, benzimidazole and benzoxazole derivatives as potential antitumor agents: synthesis and preliminary in vitro biological evaluation.
    Xiang P; Zhou T; Wang L; Sun CY; Hu J; Zhao YL; Yang L
    Molecules; 2012 Jan; 17(1):873-83. PubMed ID: 22252503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro cytotoxicity of benzoxazole-based PPARα/γ antagonists in colorectal cancer cell lines.
    Moreno-Rodríguez N; Laghezza A; Cerchia C; Sokolova DV; Spirina TS; De Filippis B; Romanelli V; Recio R; Fernández I; Loiodice F; Pokrovsky VS; Ammazzalorso A; Lavecchia A
    Arch Pharm (Weinheim); 2024 Sep; 357(9):e2400086. PubMed ID: 38807029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.